NIH Tag

Cellectar Biosciences has been awarded a $2 million Phase II National Institutes of Health (NIH) SBIR grant from the National Cancer Institute (NCI), the company announced recently. According to a release, the grant will support a pivotal study of iopofosine I-131 in Waldenstrom’s Macroglobulinemia. “We appreciate the recognition...